Third Rock’s Mark Levin Warns of System-Wide Failure To Support Young Biomedical Companies
This article was originally published in The Pink Sheet Daily
Executive Summary
Third Rock Partner Mark Levin is excited about emerging science, but somewhat pessimistic about the environment for companies pursuing it.